The Advanced Research Projects Agency for Health (ARPA-H) has unveiled a new funding opportunity titled “Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx)” under the number 75N99224R00001. This discretionary cooperative agreement aims to support innovative research in the field of viral efficacy prediction and vaccine development. ARPA-H anticipates making multiple awards of various types as a result of this announcement.
The APECx program focuses on leveraging computational experimentation to predict antigens with broad viral efficacy, potentially revolutionizing the way vaccines are developed and diseases are combated. Interested parties are encouraged to submit abstracts by December 15, 2023, with invited proposals due by February 16, 2024. This initiative represents a significant step in ARPA-H’s mission to accelerate biomedical innovation and improve public health outcomes through transformative projects and research.
Opportunity ID: 351039
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | 75N99224R00001 |
| Funding Opportunity Title: | Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | |
| Expected Number of Awards: | |
| CFDA Number(s): | 93.384 — ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 21, 2023 |
| Last Updated Date: | Nov 21, 2023 |
| Original Closing Date for Applications: | Jan 19, 2024 |
| Current Closing Date for Applications: | Feb 16, 2024 |
| Archive Date: | Feb 18, 2024 |
| Estimated Total Program Funding: | |
| Award Ceiling: | $ |
| Award Floor: | $ |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | Please see BAA for eligibility information. |
Additional Information
| Agency Name: | Advanced Research Projects Agency for Health |
| Description: | The Advanced Research Projects Agency for Health (ARPA-H) posts this funding opportunity in support of its Antigens Predicted for Broad Viral Efficacy through Computational Experimentation (APECx) Program. ARPA-H anticipates multiple awards and award types will result from this announcement.
Interested parties are invited to review attached APECx Research & Development Solicitation No. 75N99224R00001. Abstracts are due December 15, 2023, 9:00 AM ET. Proposals will be invite-only and will be due February 16, 2024, 5:00 PM ET. An abstract must be submitted to be invited to submit a proposal. Please ensure to follow this opportunity for any updates. For more information about APECx, please visit https://arpa-h.gov/engage/programs/apecx/. Please note that the APEX Accelerators government contracting resource for small businesses notice is included on all SAM.gov postings and is unrelated to the ARPA-H APECx program. |
| Link to Additional Information: | SAM.Gov link to the RDS |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact: APECx@arpa-h.gov
|